April 03, 2018 - Akers Biosciences Inc. (NASDAQ:AKER) has filed a financial statement reporting Shares Float of $10,201,326 USD. Previously, on March 30, 2016, Akers Biosciences Inc. reported Shares Float of $22,380,041 USD. This represents a change of -54.42% in Shares Float.
Related News Stories
Today we will discuss Reata Pharmaceuticals (RETA), which provided an update on the phase 2 portion of the CARDINAL study of bardoxolone methyl (bardoxolone) in patients with chronic kidney disease (CKD) due to Alport syndrome. (63-14)
Good morning, and welcome to the Akers Biosciences Conference Call to discuss 2017 Earnings. As a reminder, this conference call is being recorded. I would now like to introduce your host for today’s conference, Ben Simons with Akers Corporate Communications team. (3-14)
Flex Pharma (NASDAQ:FLKS) shares moved up sharply in early trading on Monday after the company announced positive top-line data from the phase 2 study of FLKS-787 in multiple sclerosis (NYSE:MS) patients with frequent muscle cramps/spasms and spasticity. (110-1)